Cerus (CERS) Receivables - Other (2018 - 2021)

Cerus (CERS) reported Receivables - Other of $2.7 million for Q3 2021, down 53.09% sequentially from $5.7 million in Q2 2021.

Cerus (CERS) Receivables - Other (2018 - 2021) Analysis & Trends

Cerus (CERS) has 3 years of Receivables - Other data on file, last reported at $2.7 million in Q3 2021.

  • For the quarter ending Q3 2021, Receivables - Other changed N/A year-over-year to $2.7 million; the trailing twelve-month figure through Sep 2021 stood at $2.7 million (changed N/A YoY), and the FY2020 full-year result was $2.4 million, changed N/A from the prior year.
  • Receivables - Other slipped to $2.7 million in Q3 2021, from $5.7 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $5.7 million in Q2 2021 to a low of $1.2 million in Q4 2018.
  • A 3-year average of $3.0 million and a median of $2.7 million in 2021 frame the typical range for Receivables - Other.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.88 Bn 176.59 Bn 6.27 Bn
2 Stryker 128.95 Bn 126.07 Bn 3.81 Bn
3 Medtronic 108.68 Bn 99.46 Bn 6.41 Bn
4 Boston Scientific 68.54 Bn 67.09 Bn 3.61 Bn
5 Edwards Lifesciences 48.26 Bn 44.58 Bn 1.29 Bn
6 Dexcom 28.39 Bn 27.28 Bn 750.30 Mn
7 GE HealthCare Technologies 28.22 Bn 25.93 Bn 1.98 Bn
8 Smith & Nephew 26.89 Bn 26.31 Bn -
9 Koninklijke Philips 24.66 Bn 21.54 Bn 2.07 Bn
10 Cerus 604.75 Mn 524.33 Mn 27.89 Mn

Historic Data

Download Data
DateValue
Sep 30, 2021 2.66 Mn
Sep 30, 2021 2.66 Mn
Jun 30, 2021 5.68 Mn
Jun 30, 2021 5.68 Mn
Mar 31, 2021 3.30 Mn
Mar 31, 2021 3.30 Mn
Dec 31, 2020 2.38 Mn
Dec 31, 2020 2.38 Mn
Dec 31, 2018 1.20 Mn
Dec 31, 2018 1.20 Mn